| Статус: | Completed |
| Фаза: | Phase 3 |
| Начало: | 1 июня 2008 г. |
| Окончание: | 1 ноября 2010 г. |
| Описание: | This is a Phase 3 multi-center trial designed to evaluate the clinical efficacy and safety of VIVITROL® (Medisorb® naltrexone 380 mg) versus placebo when administered to adults upon discharge from inpatient treatment for opioid dependence. The study was conducted in 2 parts, Part A and Part B. The clinical portion of both parts has completed. Results for Part B are not yet available. |
| смотреть на ClinicalTrials.gov |